publication venue for
- Corrigendum to "Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings" [Obes. Pillars, Volume 11, September 2024, 100112]. 2024
- Corrigendum to "Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022" [Obes. Pillars 3 (2022) 100032]. 2022
- Special considerations for the child with obesity: An Obesity Medicine Association (OMA) clinical practice statement (CPS) 2024.. 11. 2024
- Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings.. 11. 2024
- Special considerations for the adolescent with obesity: An obesity medicine association (OMA) clinical practice statement (CPS) 2024.. 9. 2023
- Letter to the Editor of ObesityPillars from the Obesity Medicine Fellowship Council.. 6. 2023
- Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023.. 6. 2023
- Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022.. 4. 2022
- Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022.. 3. 2022
- Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022.. 3. 2022
- Obesity pillars roundtable: Obesity and individuals from the Mediterranean region and Middle East.. 2. 2022
- Assessment, differential diagnosis, and initial clinical evaluation of the pediatric patient with obesity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022.. 1. 2022
- Clinical review: Guide to pharmacological management in pediatric obesity medicine. 2023